Testing effectiveness (Phase 2)WithdrawnNCT01550380What this trial is testingBKM120 in Advanced, Metastatic, or Recurrent Endometrial CancersWho this might be right forEndometrial Cancer University of Utah
Large-scale testing (Phase 3)Study completedNCT04865289What this trial is testingPembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension StudyWho this might be right forEndometrial Neoplasms Merck Sharp & Dohme LLC 130
Early research (Phase 1)Looking for participantsNCT07227168What this trial is testingSTRO-004 in Adults With Refractory/Recurrent Metastatic CancerWho this might be right forHead and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more Sutro Biopharma, Inc. 200
Early research (Phase 1)Study completedNCT01440998What this trial is testingDasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more National Cancer Institute (NCI) 18
Not applicableStudy completedNCT02506816What this trial is testingPreoperative Olaparib Endometrial Carcinoma Study (POLEN)Who this might be right forEndometrial Carcinoma MedSIR 36
Testing effectiveness (Phase 2)Study completedNCT04080284What this trial is testingTrial of Maintenance With Niraparib- Uterine Serous CarcinomaWho this might be right forEndometrial CancerPapillary Serous Endometrial CarcinomaUterine Serous Carcinoma+2 more Northwell Health 22
Not applicableLooking for participantsNCT06549855What this trial is testingPD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial CancerWho this might be right forEndometrial CancerEndometrioid CarcinomaMismatch Repair Deficiency Peking University People's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT05941507What this trial is testingEvaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors LigaChem Biosciences, Inc. 300
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83
Testing effectiveness (Phase 2)Ended earlyNCT04577963What this trial is testingFruquintinib in Combination With Tislelizumab in Advanced Solid TumorsWho this might be right forTriple Negative Breast CancerEndometrial CancerSolid Tumor, Unspecified, Adult+1 more Hutchmed 52
Post-approval studies (Phase 4)Study completedNCT06049693What this trial is testingIron Prehabilitation in Endometrial CancerWho this might be right forEndometrial CancerPerioperative ComplicationPrehabilitation National and Kapodistrian University of Athens 156
Not applicableUnknownNCT04894552What this trial is testingComplications of Laparoscopic Hysterectomy and Sentinel Lymph Node Biopsy for Endometrial CarcinomaWho this might be right forLaparoscopic Hysterectomy and Sentinel Lymph Node Biopsy Ain Shams Maternity Hospital 20
Large-scale testing (Phase 3)Study completedNCT03603184What this trial is testingAtezolizumab Trial in Endometrial Cancer - AtTEndWho this might be right forEndometrial Cancer Mario Negri Institute for Pharmacological Research 549
Testing effectiveness (Phase 2)Study completedNCT03926936What this trial is testingFUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia StudyWho this might be right forEndometrial Stromal SarcomaAdenosarcoma of UterusLeiomyosarcoma Uterus+3 more Frederic Amant 17
Not applicableUnknownNCT06279832What this trial is testingRadiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.Who this might be right forEndometrial Cancer Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,000
Early research (Phase 1)Study completedNCT02269293What this trial is testingSelective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial CancersWho this might be right forOvarian CancerEndometrial Cancer Memorial Sloan Kettering Cancer Center 23
Not applicableUnknownNCT05227898What this trial is testingVirtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With CancerWho this might be right forCancer Blue Note Therapeutics 352
Early research (Phase 1)Looking for participantsNCT07503808What this trial is testingIDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors TypesWho this might be right forEsophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more IDEAYA Biosciences 150
Not applicableStudy completedNCT01430208What this trial is testingA New Alternative to Traditional HysteroscopyWho this might be right forIntrauterine DiseasesMyomasPolyps Catholic University of the Sacred Heart 401
Not applicableStudy completedNCT04000880What this trial is testingAdapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthWho this might be right forBreast CancerColorectal CancerEndometrial Cancer+6 more University of Alabama at Birmingham 603